Real-World Response and Super-Response to Eptinezumab over 48 Weeks in Migraine: The Prospective Multicenter EMBRACE III Study.
Saved in:
| Title: | Real-World Response and Super-Response to Eptinezumab over 48 Weeks in Migraine: The Prospective Multicenter EMBRACE III Study. |
|---|---|
| Authors: | Barbanti, Piero1,2 (AUTHOR), Aurilia, Cinzia1 (AUTHOR), Filippi, Massimo3 (AUTHOR), Doretti, Alberto4 (AUTHOR), d’Onofrio, Florindo5 (AUTHOR), Scatena, Paola6 (AUTHOR), Vecchio, Rosario7 (AUTHOR), Messina, Roberta3 (AUTHOR), Vinciguerra, Luisa8 (AUTHOR), Ranieri, Angelo9 (AUTHOR), Baldisseri, Francesco10 (AUTHOR), Torelli, Paola11 (AUTHOR), Russo, Marco12 (AUTHOR), Cutrona, Carolina13 (AUTHOR), Viticchi, Giovanna14 (AUTHOR), Egeo, Gabriella1 (AUTHOR), Autunno, Massimo15 (AUTHOR), Pistoia, Francesca16 (AUTHOR), Finocchi, Cinzia17 (AUTHOR), Camarda, Cecilia18 (AUTHOR) |
| Source: | Neurology & Therapy. Jun2026, p1-20. 20p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
